Effect of salbutamol and magnesium sulfate nebulizer compared with salbutamol and normal saline nebulizer in the treatment of acute asthma attack
Not Applicable
- Conditions
- Pediatric asthma.Asthma, unspecified
- Registration Number
- IRCT201110024396N3
- Lead Sponsor
- Vice chancellor for research, Babol University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Children aged 5-14 years, suffering from moderate or severe asthma with asthma attack
Exclusion criteria:
History of steroid therapy, theophylline, Atrovent in the past three days; a history of chronic diseases such as Bronchopulmonary dysplasia, cystic fibrosis and known allergy to magnesium sulphate and salbutamol and the inability to perform peak flow meter
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Increase of PEFR (Peak Expiratory Flow Rate). Timepoint: 0,30,60 and 90 minutes after entrance. Method of measurement: With peak flow meter.
- Secondary Outcome Measures
Name Time Method Pulmonary index. Timepoint: At 0, 30, 60 , 90th minute. Method of measurement: By using Pulmonary index table.